The tenth anniversary of the
Chemical and Biological Medical Treatment (CBMTS) series:
First Announcement Update

    CBMTS V Spiez Laboratory    

ASA

Spiez Laboratory   DPA   Spiez, Switzerland
25-30 April 2004
   

________________________________________________________________________________

A. Objective:

Bring together the CBMTS professionals most concerned with and directly involved in the scientific and technical aspects of problems associated with the CBR threat to include all actions associated with CBR agent, agrichemical, agrochemical and industrial poisonings. These problems include medical treatment (prophylaxis, pre-treatment and therapy) required for CB agent, agrichemical and industrial poisonings; emergency management required for accidents and incidents; and operational issues from across the response spectrum. Contributions of papers and posters from each research and operational area are solicited. The CBMTS V is also very pleased to continue with its original efforts of many years on the topic of chemical and biological terrorism and anti-terrorism matters.

B. Symposium Model:

To ensure the free flow of ideas, the CBMTS V will again use the Gordon Research Conference approach in the conduct of the Symposium. We expect this conference to continue with the CBMTS tradition of a relaxed shirt-sleeve environment, a first name basis in very short order, and as always a very enjoyable camaraderie between all participants; professionals from well over 30 countries.

C. Who Should Attend?

Industry, government and academic professionals with an interest in the chemical, biological, and radiological threat, whether the threat is from war, terrorist actions or accidents and incidents, natural or man-made. Medical, public health and medical research professionals, including primary care physicians, practitioners and veterinarians; Local, regional and national laboratory representatives; first responders and HAZMAT specialists, including emergency, crisis management and mitigation, and civil defense personnel; industry scientists and engineers; and specialists in computer risk modeling and planning, training and local community interface.

D. Call for papers/topic and theme areas

Papers could cover any one or a combination of the listed topic areas and sub-areas as well as areas not listed. For ‘non-listed’ areas, the author should show how the subject does fit with the theme of the CBMTS V. Please consider the theoretical as well as the practical and the scientific and operational in problem definition, preparation and response. The importance of local, national, regional, and international preparation and response will be of the highest interest to all professionals attending the CBMTS V.
The following listed major topic, sub-topic areas will be further updated and changed per participants’ requests and at planned meetings of the CBMTS Planning Group at the Spiez Laboratory in Spiez, Switzerland.
(Important Note: CBMTS V will be held under the CBMTS rules that state all participants will present a Science Review Committee approved paper either from the podium or from a poster. Additionally, the CBMTS V Symposium has a physical limit of approximately 130 participants maximum and this will also limit the number of Papers that may be accepted.)

E. The proposed topic areas (and sub-areas are the guide for the proposed papers):

  1. CBR Agents: characterization and mode of action
  2. Analysis: identification, quantitation of substances; threat assessment; rapid differentiation between biological, toxin and chemical incidents.
  3. Prevention: includes threat consideration, terrorists acts, acts of war, industrial accidents and incidents, considerations in CW destruction.
  4. Protection and decontamination: includes operational, physical, and medical including prophylaxis.
  5. Mass Casualty Management: CBR victims in the event of major accidents or incidents and from war/combat actions or terrorist attacks to include differentiation, identification, prevention, pre-planning, organization, and interface with military/civil medical authorities.
  6. Treatment: CBR casualties from short to long term and follow up.
  7. Terrorism: its effect on the civilian and military communities. These topics from across the CBR spectrum include new chemical agents, biological agents, toxins, new treatments, bioterrorism, new detection and decontamination capabilities as apply to CBR casualties, and etc.
  8. Training: of First Responders in terrorism, accidents, and incidents when reliance on other government agencies such as military is not feasible.
  9. Medical issues include: Pharmaceutical and Medical Equipment Stockpiles; Medical Countermeasures; Commercial and Regulatory issues; Infectious diseases; Public Health Preparedness; Vaccine development and distribution and legal issues

Note: For questions on applicability of proposed papers, the Science Review Committee will help determine either the proper area or they will form a new area.

The below outline provides guidance on the individual session areas as formulated from the proposed topic areas. The CBMTS members may recommend additional areas and/or changes, which will be considered by the CBMTS V Science Advisor and Science Review Committee.

Major Session Areas

1. Medical treatment

Chemical

Nerve and blistering agents, HCN, irritants, industrial toxic compounds (list 3)
Mid- and long term effects
Means (protection, decontamination, antidotes) and preparation/instruction of first responders; concepts and reality
Mass casualty handling: triage, civilians, children, babies, decontamination on site, hospital
Detection on site
Outlook on novel threats
Oximes: which one for what agent

Biological

Agents of concern: biotoxins, pathogenic organisms
Hospital capacities and capabilities
Ranking of threat
Diagnosis, diagnostic kits
Vaccines, antisera and other treatments; state of the art on new ones, on clinical trials

Radiological

Detection of contamination
Decontamination
Medication, standard treatment
Prevention
Long term effects: medical, psychological

2. Mass casualty management

Plans for community, industry

Infants
Actual state of the art
Lesson from exercises: what worked and what did not
Training of first responders
On hand equipment and procedures

3. Terrorism

Deliberate distribution through human vectors
Novel agents
Zoonosis (spreading of animal diseases in humans)

4. Pharmaceuticals and Vaccines

Protective medication
Preventive vaccination

5. Detectors and Decontamination

6. Physical and Individual Protection

Protective Clothing
Protective Equipment

F. Important Dates:

1. Administrative Dates:
Pre-registration. As soon as possible. This is only a notification of intent to Register. Note: An Abstract will be presented and accepted by the Science Review Committee prior to final Registration.
Early registration - prior to 25 February. Upon approval of Abstract - registration will be accepted and Invitation Letter forwarded to participant.
From 25 February - registration with increased fees
1 April. Final papers are due not later than 1 April and preferably earlier. Upon receipt and approval of Paper submission, an “Invitation Letter” will be issued.
25 April. CBMTS V.

2. Abstract/Paper/Invitation Letter Dates
• 15 December or earlier- Abstract due
• 30 January or earlier - Draft Paper due
• 28 February - Invitation Letter (based on acceptance of Abstract/Paper) for VISA application due to participants
• 31 March - last date for Invitation Letters. Preferably Invitation Letters will be be able to be sent earlier.
• 25 April - Start date for CBMTS V.

G. Important Numbers:

The CBMTS web address: http://www.asanltr.com/cbmts/default.htm

For the CBMTS V team:

  1. ASA. CBMTS and International: Richard Price at tel: 1-410-638-9480 and fax: 1-410-638-9481 and e-mail: cbmts@asanltr.com and
  2. Spiez Laboratory and Switzerland. Irma Lehnherr at tel: 41-33-228-1586 and fax: 41-33-228-1402 and e-mail: irma.lehnherr@babs.admin.ch
  3. CBMTS Science:Prof. Urs Brodbeck through cbmts@asanltr.com and irma.lehnherr@babs.admin.ch .

Note: On all message traffic, please include the ASA and Spiez Laboratory e-mail and/or fax addresses and the word CBMTS in the subject.

H. Pre-registration and information:

          Please forward at the earliest time to ASA and to Switzerland, your pre-registration information to include name; organization, tel/fax and e-mail numbers, proposed paper title. The data requested will also be on the CBMTS V registration form.

I. Abstract Submission:

          Abstracts on above Topic Areas will be 250 words or less and presented in the following format via e-mail:

  1. Title (in bold, 14 point Times, left justified, all caps)
  2. Presenting author and organization, address, telephone, fax, and e-mail (Initial cap, bold, left justified, 12 point Times); other authors and organizations (same as above, but not bold)
  3. Body of Abstract: No tables, figures or references are to be used in abstract, and, a maximum of five keywords.

Full information on the Abstract and Paper formats will be located on the CBMTS V web site: http://www.asanltr.com

J. The CBMTS V E-mail Network.

          For all prospective participants who would like update information on this CBMTS V meeting, please forward your preferred e-mail address for entry into the CBMTS Update network. Send your e-mail address to: cbmts@asanltr.com. On all messages to ASA and the Spiez Laboratory, put CBMTS V in subject line.

K. The CBMTS Web-Site.

          General information, sector, topic and theme areas, pre-registration and registration forms, and abstract/paper submission information, are at or can be accessed from the ASA web site for CBMTS V http://www.asanltr.com/cbmts/cbmts/V/CBMTSV.htm
Please look at the CBMTS page for registration form, etc.-http://www.asanltr.com/cbmts/default.htm.

L. Requirements for Attendance:

          Participation is based primarily on abstract acceptance and/or geographical representation. All participants are expected to submit a paper. After abstract acceptance by CBMTS International Science Review Committee, a notification will be sent that Registration would be accepted.

M. Venue: The Spiez Laboratory.

N. Host and Sponsor:

         The CBMTS V will be hosted and sponsored by the Government of Switzerland and the Spiez Laboratory. The Spiez Laboratory CBMTS team is providing in-depth operational, planning, and administrative support that is very crucial to the success of CBMTS V.

O. Symposium fees/living costs for CBMTS V:

          Payment Information: Registration and other fees. Credit cards (AMEX, VISA, MC); bank transfer, bank check. Contact ASA for specific details (cbmts@asanltr.com).

Registration Fee

Individual Members before 25 Feb after 25 Feb
Government/Academia CHF 890 CHF 1080
Industry CHF 1180 CHF 1390

The Registration Fee includes:

  • all lunches at the Laboratory Dining Room from Monday 26 April through Friday 30 April 2004
    all dinners at the Hotel Royal St. Georges in Interlaken from Monday 26 April through Friday 30 April 2004
    Welcome Party on Sunday evening
    Symposium Dinner
    Program, Proceedings, Symposium bag, local transportation for scheduled events and other items
    Excursion and Farewell Party with Dinner
  • Accompanying Persons Fees: Lunch CHF 16, Dinner CHF 28, Welcome Party CHF 30, Symposium Dinner CHF 90, Excursion and Dinner CHF 50.
  • The excursion includes the Tr¸mmelbach Waterfalls and its ten glacial water falls inside the mountain. Made accessible by tunnel lift, the Tr¸mmelbach waterfalls are truly unique in Europe. Tr¸mmelbach alone drains the enormous glacial walls of the Eiger (3970 m), M–nch (4099 m) and Jungfrau (4158 m) with up to a spectacular 20,000 litres of water per second. This stems from a catchment area of 24 square kilometers of which approximately half is covered with snow and ice. After this excursion and if possible, we will have a boat ride on Lake Brenz to include the farewell dinner.

Note: There is a CHF 50 fee per each accompanying person for the Excursion and Farewell Dinner.

P. Accommodations

          All members of CBMTS V will be accommodated in Interlaken, the world-famous, scenic village situated between two magnificent lakes (approx. 20 km from Spiez). There will be a shuttle bus between Spiez and Interlaken.

Please note that there are two railway stations in Interlaken: When entering into Interlaken, first stop is "Interlaken West", second stop, after approx. 5 min., is "Interlaken Ost" (East). Individuals staying at the Hotel Royal St. Georges leave the train at "Interlaken Ost". Individuals staying at the Hotels Chalet Oberland or Harder-Minerva get off the train at "Interlaken West". All hotels are within walking distance from the respective railway station.
Please consider this difference of railway stations when buying the rail ticket at the airport.

CBMTS V Hotels in Interlaken
All rooms with bath/shower, toilet, phone, TV, minibar
Price includes: breakfast and all prices are per room/per night

Hotel Royal St. Georges (4 Star) www.royal-stgeorges.ch
(20 single rooms, 30 double rooms)

Single room CHF 130 room/night
Double room with single occupancy CHF 150
Double room CHF 200

Hotel Chalet Oberland (3 Star) www.chalet-oberland.ch
(45 double rooms)

Double room with single occupancy CHF 110
Double room CHF 170

Hotel Harder-Minerva (2 Star) www.harder-minerva.ch or www.InterlakenTourism.ch
(10 single rooms)

Single room CHF 90

Q. Refund Policy:

  1. Hotels: Hotels will be guaranteed upon receipt of the symposium registration fee from each individual. If an individual does not show for his hotel reservation date and has not provided at least 24 hours notice prior to the 'no-show' then one night hotel fee will be taken from the individual's symposium registration fee.
  2. Registration Fees and Refunds
    Until 08 March = 90% refund (- 10% = bankcharge)
    From 09 March = 80% refund of registration fee
    From 01 April to 18 April = 60% refund of registration
    After 18 April = no refund

R. Registration/other fees:

Payment and Bank data
Payments are accepted by credit cards Visa, Master Card, EuroCard, Diners Club and American Express. Payment is also accepted via bank transfer or bank check, or by cash at registration if prior approval has been obtained.
•• Bank data for CBMTS:
Bank data for CBMTS V Switzerland:
Address: Berner Kantonalbank, Filiale Spiez, Kronenplatz, CH-3700 Spiez, Switzerland
Account No. 42 3.694.965.22
Swift code: KBBECH2237A
Bankclearing No. 79030

S. Registration Forms

The form is available at http://www.asanltr.com/cbmts/REG_CBMTSV.htm

Please remember to provide the name, if appropriate, of the Accompanying Person(s) and note on the Hotel Request the specific type of hotel room required; such as:

Hotel Royal St. Georges

Single room
Double room with single occupancy
Double room

Hotel Chalet Oberland (45 double rooms)

Double room with single occupancy
Double room

Hotel Harder-Minerva (10 single rooms)
Single room

The allocation of the rooms will be made on the "first in – first served" basis.

T. Fellowships:

          Assistance for individuals to attend CBMTS V. Limited support of professionals from developing countries and countries with economies in transition. The requirements for fellowship consideration are that the individual submit a paper to be presented at the CBMTS V and that paper be approved by the Science Review Committee. The goal for the CBMTS Organizing Committees is to be able to provide: Registration Fee, Accommodations and return fare to Zurich or Geneva and train to Spiez. Recognizing that available funds for Fellowships will be limited, the CBMTS Organizing Committee will more favorably consider specific requests for lesser amounts from individuals wishing to attend.

U. Information on Sponsors/Sponsorship:

Crucial to the success of the CBMTS V are the sponsorship of the Government Organizations, Institutions and Industries that are a vital part of these CBMTS Symposia. Sponsorship funding provides the primary source of revenue used to assist many of our CBMTS professionals to attend the CBMTS meetings. To date, these funds have been used to assist participants from developing countries and countries with economies in transition. The CBMTS V is hosted and in part sponsored by the Spiez Laboratory with the Government of Switzerland. The CBMTS International Organization, with the CBMTS series originator, Applied Science and Analysis Inc., work in partnership with the host to ensure that each meeting meets the goals and objectives of the Swiss Laboratory and the CBMTS.


There are three sponsorship levels for CBMTS meetings:

  1. Co-sponsor. Includes up to two industry registrations plus half page advert space in the Program and Proceedings plus one half page space in the ASA Newsletter. Includes a booth space at the CBMTS Spiez Laboratory.
  2. Sponsor. The above plus full page in Program, Proceedings, ASA Newsletter plus up to three industry registrations.
  3. Major Sponsor. Above plus up to four Registrations.


Note 1: Please contact ASA for Sponsor letter which outlines the many benefits of sponsoring the CBMTS.
Note 2: To be fair to our Major Sponsors, Sponsors, and Co-sponsors, these three categories will be the only participants permitted to import, display and discuss their products at CBMTS V.

A special note for our Sponsors who wish to exhibit equipment: if you want to send material to the symposium venue, you are requested to please contact Ms irma Lehnherr at e-mail: irma.lehnherr@babs.admin.ch. Shipping instructions and additional informations will then be delivered.

V. CBMTS V Organization:

HOST AND SPONSOR

• SPIEZ LABORATORY, Spiez Switzerland
•• Director: Dr. Marc Cadisch

ORGANIZERS

• SPIEZ LABORATORY, Organizing Committee
• Applied Science and Analysis Inc, (ASA)
Bel Air, Maryland U.S.A
• Federal Commission for NBC-Protection, Switzerland

HONORARY SYMPOSIUM DIRECTORS

• Juan F. Gut, Secretary General, Federal Department of Defence, Civil Protection and Sports
• Willi Scholl, Director, Federal Office for Civil Protection

SYMPOSIUM DIRECTOR

• Bernhard Brunner, President, Federal Commission for NBC-Protection

SYMPOSIUM CO-DIRECTORS

• Richard Price, ASA
• Marc Cadisch, Spiez Laboratory

CHAIRS

• Symposium Chair: Brian Davey
• Symposium Co-Chair: Barbara Price
• Symposium Co-Chair: Urs Brodbeck

CBMTS V

25.-30 April 2004 in Spiez and Interlaken

Symposium Committees
Executive Organizing Committee

Peter Hunziker, President
Irma Lehnherr, Symposium Secretary
Werner Arnold
Bernhard Brunner
Chris Fokas
Kurt M¸nger
Christa Reber
Alex Werlen
a part time secretary
Instructors BABS

Science Review Committee

Urs Brodbeck, President
Bernhard Brunner
Emmanuel Egger
Ueli Huber
Martin Sch¸tz
Peter Siegenthaler
Toni Wicki

____________________________________

CBMTS Intertnational Science Review Committee

a. Dr. Barbara Price, Chair, Battelle Memorial Institute, Aberdeen, Maryland USA
b. Prof. Urs Brodbeck, Bern, Switzerland
c. Prof. Sergey Netesov, VECTOR, Novosibirsk, Russia
d. Dr. Bhupendra Doctor, WRAIR, Washington, DC USA
e. Dr. David Moore, Battelle Memorial Institute, Aberdeen, Maryland USA
f. Prof. Ladislaus Szinicz, IPT, Armed Forces Medical Academy, Munich, Germany
g. Prof. Jiri Bajgar, PMMA, Hradec Kralove, Czech Republic
h. Dr. Slavko Bokan, NBC Lab, Zagreb, Croatia
i. Dr. Murray Hamilton, Center Homeland Defense, Colorado USA
j. Dr. Robert DeBell, Battelle Memorial Institute, Arlington, Virginia USA
k. Dr. Tim Merdith, WHO, Geneva, Switzerland
l. Dr. Gabrielle Kraatz-Wadsack, Foreign Ministry, Berlin, Germany
j. Dr. Martin Sch¸tz. Spiez Laboratory, Switzerland
k. Dr. Ueli Huber, Spiez Laboratory, Switzerland

The CBMTS International Executive Committee

a. Richard Price, Chair, ASA, USA
b. Marc Cadisch, Spiez Laboratory Switzerland
c. Bernhard Brunner, Federal Commission for NBC-Protection, Switzerland
d. Steve Bice, CDC/SNS, USA
e. Brian Davey, OPCW, The Netherlands
f. Cornelis Erasmus, Protechnik Laboratories, South Africa
g. Leo Laughlin, Florida USA
h. Peter Hunziker, Spiez Laboratory Switzerland
i. Irma Lehnherr, Spiez Laboratory Switzerland
j. Zvonko Orehovec, MOD, Croatia
k. Joe Hughart, ATSDR, USA
l. Douglas Eaton, NBC Team Ltd., Canada
m. Thomas Werk, EMD Pharmaceuticals, North Carolina, USA
n. Eric Stephen, DRDC Ontario, Canada
o. David Trudil, New Horizons, USA
p. Keith Vesely, DTRA, USA

Return to the ASA CBMTS webpage

Last updated 3 November 2003, BBSP